Revolutionizing Data Collection in Cardiology with Proprietary Wireless Ecosystem
SALT LAKE CITY – November 3, 2023 – BioUtah today announced the winners of its 2023 Life Sciences Awards. Five awards will be presented during the 2023 Mayer Brown Utah Life Sciences Summit Nov. 9 at the Salt Palace, in Salt Lake City. BioUtah’s annual awards recognize leaders, innovators and entrepreneurs who have made significant […]
Springville, Utah, October 27, 2023—ATL Technology, a dynamic and rapidly expanding company specializing in medical device development and manufacturing, is thrilled to introduce Danelle Goulet as the new Vice President of Human Resources. Expressing her enthusiasm for her new role, Danelle shared, “I am excited by the challenge of a fast-growing company in the medical […]
BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J. (April 11, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched a new, easy-to-use advanced ultrasound device with a specialized probe designed to provide clinicians with […]
First-in-Human Study of Novel Oral Dual-Acting Antibody in Development for Treatment of Patients with Inflammatory Bowel Disease SALT LAKE CITY, UT, UNITED STATES, November 1, 2023 /EINPresswire.com/ — Sorriso Pharmaceuticals, a biopharmaceutical company developing novel oral antibodies in immune-mediated disease, today announced that the first subject has been dosed in the company’s Phase 1/1b clinical […]
SALT LAKE CITY – October 27, 2023 –BioUtah, Utah’s trade association serving the state’s life sciences community, announced today Myles Greenberg, MD, MBA, CEO of Alucent Biomedical, as the new board chair, effective January 2024. Dr. Greenberg, an experienced life sciences entrepreneur, venture investor, and board-certified emergency physician, succeeds Andrea Kendell, chief financial officer at […]
Partnership covers development of lab-developed and distributable kit-based companion diagnostic tests Combined strengths in assay development, clinical testing, and regulatory approvals offers pharma partners comprehensive global companion diagnostic solutions based on PCR, digital PCR (using the QIAcuity system), and NGS Future projects may include advanced analysis and accessibility of measurable residual disease (MRD) and homologous […]
Unveiling the Power of Epigenetics in Male Fertility: A New Horizon Beyond Semen Analysis
The company expects to receive U.S. approval late next year.
SALT LAKE CITY, UT, October, 18, 2023 – Seek Labs, a healthcare innovations company doing research in infectious disease diagnostic systems and pharmaceuticals, is pleased to announce its participation at the Animal Health, Nutrition & Technology Innovation Asia Summit in Tokyo, Japan. Craig Mosman, Chief Business Development Officer, was invited to speak on behalf of […]
Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding Salt Lake City, UT – October 18, 2023 – DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced a basic science Cooperative Research and […]
Company Ranks Top 2 in Healthcare Equipment and Services Industry
Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions
After the release of the first IVDR certificate at the beginning of the year ELITech Group continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories.
CLP Magazine recently interviewed Kristen Smith, senior medical science liaison at bioMérieux
Once-daily, steroid-free roflumilast foam 0.3% demonstrated significant improvements in both scalp and body psoriasis
ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award
New multipurpose microcatheter length complements Merit’s radial-first legacy
GE and Mayo Clinic plan to collaborate on imaging, artificial intelligence and cancer treatment.
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
Funding to Support Research and Expanded Access of Investigational Drug in ALS SALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological […]
LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children’s Hospital […]
New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood
Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding
Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility
Audio-based Detection of Anxiety and Depression via Vocal Biomarkers
Marcy-l’Étoile (France), September 22nd, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has submitted the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to U.S. Food and Drug Administration (FDA) for a dual 510(k) clearance and CLIA1-waiver. This panel is already CE-marked (IVDD2).
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in […]
SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its second annual Environmental, Social and Governance report, highlighting key efforts that reflect its commitment to conduct operations as a responsible, equitable and sustainable partner in the healthcare industry. “At Myriad, […]
Rep. Moore’s Health Staff Tours Visits Utah Life Sciences Companies
Civica Rx, a health care utility co-founded by SSM Health, supplies critical medications that patients need.
rant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools
